Slate Stone Wealth, LLC Abbott Laboratories Transaction History

Slate Stone Wealth, LLC

$1.11 Billion
Q3 2024

A detailed history of Slate Stone Wealth, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Slate Stone Wealth, LLC holds 40,352 shares of ABT stock, worth $4.63 Million. This represents 0.41% of its overall portfolio holdings.

Number of Shares

40,352

Previous 48,148 16.19%

Holding current value

$4.63 Million

Previous $5 Million 8.04%

% of portfolio

0.41%

Previous 0.54%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 07, 2024	SELL	$100.07 - $118.13 $780,145 - $920,941	-7,796 Reduced 16.19%	40,352 $4.6 Million
Q2 2024 Jul 25, 2024	BUY	$100.73 - $112.44 $40,795 - $45,538	405 Added 0.85%	48,148 $5 Million
Q1 2024 Apr 26, 2024	BUY	$109.52 - $120.96 $705,637 - $779,345	6,443 Added 15.6%	47,743 $5.43 Million
Q4 2023 Feb 01, 2024	SELL	$90.19 - $110.4 $39,052 - $47,803	-433 Reduced 1.04%	41,300 $4.55 Million
Q3 2023 Oct 12, 2023	BUY	$95.53 - $114.62 $2.7 Million - $3.24 Million	28,259 Added 209.73%	41,733 $4.04 Million
Q2 2023 Aug 07, 2023	SELL	$100.78 - $112.29 $67,623 - $75,346	-671 Reduced 4.74%	13,474 $1.47 Million
Q1 2023 Aug 08, 2023	BUY	$96.86 - $114.01 $21,309 - $25,082	220 Added 1.63%	13,694 $1.39 Million
Q4 2022 Feb 01, 2023	BUY	$95.06 - $111.52 $357,045 - $418,869	3,756 Added 36.15%	14,145 $1.55 Million
Q3 2022 Nov 03, 2022	SELL	$96.76 - $112.03 $731,989 - $847,506	-7,565 Reduced 42.14%	10,389 $1.01 Million
Q2 2022 Aug 04, 2022	SELL	$102.07 - $123.37 $173,008 - $209,112	-1,695 Reduced 8.63%	17,954 $1.95 Million
Q1 2022 May 04, 2022	SELL	$114.02 - $139.04 $560,408 - $683,381	-4,915 Reduced 20.01%	19,649 $2.33 Million
Q4 2021 Feb 02, 2022	BUY	$115.53 - $141.46 $1.64 Million - $2 Million	14,156 Added 136.01%	24,564 $3.46 Million
Q3 2021 Oct 28, 2021	BUY	$116.66 - $129.06 $184,906 - $204,560	1,585 Added 17.96%	10,408 $1.23 Million
Q2 2021 Aug 02, 2021	BUY	$105.79 - $124.53 $455,425 - $536,101	4,305 Added 95.29%	8,823 $1.02 Million
Q1 2021 Apr 19, 2021	SELL	$108.84 - $128.23 $1,741 - $2,051	-16 Reduced 0.35%	4,518 $541,000
Q4 2020 Jan 25, 2021	SELL	$105.0 - $114.42 $409,395 - $446,123	-3,899 Reduced 46.24%	4,534 $496,000
Q3 2020 Oct 27, 2020	SELL	$91.64 - $111.29 $52,234 - $63,435	-570 Reduced 6.33%	8,433 $918,000
Q2 2020 Jul 29, 2020	BUY	$76.57 - $98.0 $43,644 - $55,860	570 Added 6.76%	9,003 $823,000
Q1 2020 Apr 28, 2020	SELL	$62.82 - $91.86 $58,045 - $84,878	-924 Reduced 9.87%	8,433 $665,000
Q4 2019 Feb 06, 2020	BUY	$78.51 - $87.4 $104,575 - $116,416	1,332 Added 16.6%	9,357 $813,000
Q3 2019 Nov 05, 2019	SELL	$81.84 - $88.74 $155,496 - $168,606	-1,900 Reduced 19.14%	8,025 $671,000
Q2 2019 Aug 05, 2019	SELL	$72.88 - $85.0 $6,559 - $7,650	-90 Reduced 0.9%	9,925 $835,000
Q1 2019 May 06, 2019	BUY	$66.22 - $80.06 $49,002 - $59,244	740 Added 7.98%	10,015 $801,000
Q4 2018 Feb 13, 2019	BUY	$65.56 - $74.27 $608,069 - $688,854	9,275 New	9,275 $671,000

Others Institutions Holding ABT

# of Institutions

3,186

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $201B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Slate Stone Wealth, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Slate Stone Wealth, LLC with notifications on news.

Account

Slate Stone Wealth, LLC Abbott Laboratories Transaction History